VEGFA and lung cancer: The clinicopathological correlations with VEGF 165 expression identified in the current study for lung cancer were as follows: Lung cancer rarely occurred in patients prior to the age of 50 years and the incidence rates increased with age, peaking at ≥80 years for males and between 70 and 79 years for females (Globocan 2000; http://www.who.int/healthinfo/paper13.pdf).